199 related articles for article (PubMed ID: 32409671)
1. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome.
Willerslev-Olsen A; Buus TB; Nastasi C; Blümel E; Gluud M; Bonefeld CM; Geisler C; Lindahl LM; Vermeer M; Wasik MA; Iversen L; Becker JC; Andersen MH; Gjerdrum LMR; Litvinov IV; Litman T; Krejsgaard T; Woetmann A; Ødum N
Blood Cancer J; 2020 May; 10(5):57. PubMed ID: 32409671
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.
Vadivel CK; Willerslev-Olsen A; Namini MRJ; Zeng Z; Yan L; Danielsen M; Gluud M; Pallesen EMH; Wojewoda K; Osmancevic A; Hedebo S; Chang YT; Lindahl LM; Koralov SB; Geskin LJ; Bates SE; Iversen L; Litman T; Bech R; Wobser M; Guenova E; Kamstrup MR; Ødum N; Buus TB
Blood; 2024 Apr; 143(15):1496-1512. PubMed ID: 38170178
[TBL] [Abstract][Full Text] [Related]
3. Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
Krejsgaard T; Gjerdrum LM; Ralfkiaer E; Lauenborg B; Eriksen KW; Mathiesen AM; Bovin LF; Gniadecki R; Geisler C; Ryder LP; Zhang Q; Wasik MA; Odum N; Woetmann A
Leukemia; 2008 Dec; 22(12):2230-9. PubMed ID: 18769452
[TBL] [Abstract][Full Text] [Related]
4. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.
Heid JB; Schmidt A; Oberle N; Goerdt S; Krammer PH; Suri-Payer E; Klemke CD
J Invest Dermatol; 2009 Dec; 129(12):2875-85. PubMed ID: 19626037
[TBL] [Abstract][Full Text] [Related]
5. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
6. Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.
Woetmann A; Lovato P; Eriksen KW; Krejsgaard T; Labuda T; Zhang Q; Mathiesen AM; Geisler C; Svejgaard A; Wasik MA; Ødum N
Blood; 2007 Apr; 109(8):3325-32. PubMed ID: 17179233
[TBL] [Abstract][Full Text] [Related]
7. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion.
Jackow CM; Cather JC; Hearne V; Asano AT; Musser JM; Duvic M
Blood; 1997 Jan; 89(1):32-40. PubMed ID: 8978274
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma.
Willerslev-Olsen A; Gjerdrum LMR; Lindahl LM; Buus TB; Pallesen EMH; Gluud M; Bzorek M; Nielsen BS; Kamstrup MR; Rittig AH; Bonefeld CM; Krejsgaard T; Geisler C; Koralov SB; Litman T; Becker JC; Woetmann A; Iversen L; Odum N
J Invest Dermatol; 2021 Oct; 141(10):2449-2458. PubMed ID: 33862068
[TBL] [Abstract][Full Text] [Related]
9. Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.
Sano S; Matsui Y; Itami S; Yoshikawa K
Clin Exp Immunol; 1998 Aug; 113(2):190-7. PubMed ID: 9717967
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.
Willerslev-Olsen A; Krejsgaard T; Lindahl LM; Litvinov IV; Fredholm S; Petersen DL; Nastasi C; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Kilian M; Koralov SB; Odum N
Blood; 2016 Mar; 127(10):1287-96. PubMed ID: 26738536
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens.
Tokura Y; Yagi H; Ohshima A; Kurokawa S; Wakita H; Yokote R; Shirahama S; Furukawa F; Takigawa M
Br J Dermatol; 1995 Jul; 133(1):6-12. PubMed ID: 7669641
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.
Krejsgaard T; Willerslev-Olsen A; Lindahl LM; Bonefeld CM; Koralov SB; Geisler C; Wasik MA; Gniadecki R; Kilian M; Iversen L; Woetmann A; Odum N
Blood; 2014 Jul; 124(5):761-70. PubMed ID: 24957145
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins.
Tokura Y; Heald PW; Yan SL; Edelson RL
J Invest Dermatol; 1992 Jan; 98(1):33-7. PubMed ID: 1728639
[TBL] [Abstract][Full Text] [Related]
14. Expression of Granulysin and FOXP3 in Cutaneous T Cell Lymphoma and Sézary Syndrome.
Shareef MM; Elgarhy LH; Wasfy Rel-S
Asian Pac J Cancer Prev; 2015; 16(13):5359-64. PubMed ID: 26225678
[TBL] [Abstract][Full Text] [Related]
15. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.
Ni X; Jorgensen JL; Goswami M; Challagundla P; Decker WK; Kim YH; Duvic MA
Clin Cancer Res; 2015 Jan; 21(2):274-85. PubMed ID: 25376389
[TBL] [Abstract][Full Text] [Related]
16. Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma.
Bagot M; Echchakir H; Mami-Chouaib F; Delfau-Larue MH; Charue D; Bernheim A; Chouaib S; Boumsell L; Bensussan A
Blood; 1998 Jun; 91(11):4331-41. PubMed ID: 9596682
[TBL] [Abstract][Full Text] [Related]
17. Fulminant cutaneous T-cell lymphoma and Sézary syndrome.
Lang R; Bernheim J; Bar-Sela S; Joseph D; Ravid M
Int J Dermatol; 1986; 25(1):38-43. PubMed ID: 3485082
[TBL] [Abstract][Full Text] [Related]
18. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
19. Induction of Immunosuppressive CD8
Lee J; Park N; Park JY; Kaplan BLF; Pruett SB; Park JW; Park YH; Seo KS
J Immunol; 2018 Jan; 200(2):669-680. PubMed ID: 29237775
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells.
Döbbeling U; Dummer R; Laine E; Potoczna N; Qin JZ; Burg G
Blood; 1998 Jul; 92(1):252-8. PubMed ID: 9639524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
